ClinicalTrials.gg
Sign In

Endocarditis clinical trials

The registry lists 173 studies for Endocarditis across more than 10 countries. 57 are recruiting or about to start. 129 of them are mainly about Endocarditis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Endocarditis, Bacterial too: 182 studies, 60 open.

Get an email when these change. Save the Endocarditis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
62
Recruiting
38
Status unknown
26
Not yet recruiting
16
Terminated
15
Active, not recruiting
8

Phase

Phase 4
23
Phase 2
9
Phase 3
8
Phase 1
1

Where

France
47
United States
20
Italy
13
Germany
12
Spain
11
Denmark
10

Who runs them

Assistance Publique - Hôpitaux de Paris (9) · Central Hospital, Nancy, France (6) · Assistance Publique Hopitaux De Marseille (5) · Assiut University (5) · University Hospital, Bordeaux (4) · University Hospital, Strasbourg, France (4) · Todd C. Lee MD MPH FIDSA (3) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (3)

What is being tested here

Drugs under test in Endocarditis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Clindamycin202
Levofloxacin113
Amoxicillin113
Dicloxacillin102
Linezolid102
Oritavancin101
Doxycycline101
Ciprofloxacin101
Moxifloxacin101
Tedizolid101

Coming up

3phase 3 studies under way
14studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 38 Endocarditis studies recruiting now, 34 (89%) set no upper age limit and 1 (3%) stop at 75 or younger. 1 (3%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (5%) take healthy volunteers.

Recruiting studies that take each age, of 38
AgeWomenMen
100 (0%)0 (0%)
1838 (100%)38 (100%)
3038 (100%)38 (100%)
4038 (100%)38 (100%)
5038 (100%)38 (100%)
6538 (100%)38 (100%)
7538 (100%)38 (100%)
8536 (95%)36 (95%)

Across all 173 studies, recruiting or not: 6% stop at 75 or younger and 6% at 65; 12% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Endocarditis studies take

Of 36 observational studies under Endocarditis, half reached primary completion within 62 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase35 mo22–59 · 34 studies——
Observational62 mo36–… · 36 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 173. Browse all 173 → or search them.